AKT1 and Alzheimer disease: The PI3K/AKT/mTOR pathway is activated abnormally in AD patients’ skin lesions and peripheral T cells, as well as in the skin of DNCB-induced and oxazolone-induced AD mouse models (Xiao et al., 2017; Hu et al., 2021; Zheng et al., 2022).